The names and therapeutic indications of monoclonal antibodies must comply with current regulations, which does not prevent the development of commercial strategies around trade names. Some of these practices are based on territorial or legal considerations while others are motivated by real medical concerns. Finally, some of these have a significant financial impact on the community.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1051/medsci/2019212 | DOI Listing |
Publication Analysis
Top Keywords
[names indications
4
indications antibodies
4
antibodies facing
4
facing regulations
4
regulations pharmaceutical
4
pharmaceutical company
4
company practices]
4
practices] names
4
names therapeutic
4
therapeutic indications
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!